HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

A project funded by the United States Agency for International Development (USAID) has made significant contributions to ...

Government is set to increase investment into key industries that will bolster local manufacturing, Department of Trade, ...

The Ghana AIDS Commission (GAC) says the lack of funding can  impact negatively efforts to end AIDS as a public health threat ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

However, almost 92 percent of people living with HIV (PLHIV) and persons at risk of contracting HIV globally are consuming ‘made-in-India’ antiretrovirals (ARVs),” claimed Dr Gilada. The recent ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...